1-12 of 12
David B. Miklos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

Clinical Trials & Observations
Mark P. Hamilton, Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani, Zachary Ehlinger, Shriya Syal, Zinaida Good, Brian Sworder, Joseph Schroers-Martin, Ying Lu, Lori Muffly, Robert S. Negrin, Sally Arai, Robert Lowsky, Everett Meyer, Andrew R. Rezvani, Judith Shizuru, Wen-Kai Weng, Parveen Shiraz, Surbhi Sidana, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Bita Sahaf, David M. Kurtz, Crystal L. Mackall, Robert Tibshirani, Ash A. Alizadeh, Matthew J. Frank, David B. Miklos
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3314–3326.
https://doi.org/10.1182/bloodadvances.2024012637
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7

Clinical Trials & Observations
Armin Ghobadi, Javier Munoz, Jason R. Westin, Frederick L. Locke, David B. Miklos, Aaron P. Rapoport, Miguel-Angel Perales, Patrick M. Reagan, Joseph McGuirk, Caron A. Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O. Oluwole
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2982–2990.
https://doi.org/10.1182/bloodadvances.2023011532
Published: 2024
Includes: Supplemental data
Journal Articles

Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma

Esther H. Nie, Yi-Jiun Su, John H. Baird, Neha Agarwal, Sushma Bharadwaj, Wen-Kai Weng, Melody Smith, Saurabh Dahiya, May H. Han, Jeffrey E. Dunn, Lucas B. Kipp, David B. Miklos, Brian J. Scott, Matthew J. Frank
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1474–1486.
https://doi.org/10.1182/bloodadvances.2023011896
Published: 2024
Includes: Supplemental data
Journal Articles

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Clinical Trials & Observations
Cameron S. Bader, Anna Pavlova, Robert Lowsky, Lori S. Muffly, Parveen Shiraz, Sally Arai, Laura J. Johnston, Andrew R. Rezvani, Wen-Kai Weng, David B. Miklos, Matthew J. Frank, John S. Tamaresis, Vaibhav Agrawal, Sushma Bharadwaj, Surbhi Sidana, Judith A. Shizuru, Nathaniel B. Fernhoff, Amy Putnam, Scott Killian, Bryan J. Xie, Robert S. Negrin, Everett H. Meyer
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1105–1115.
https://doi.org/10.1182/bloodadvances.2023011625
Published: 2024
Includes: Supplemental data
Journal Articles

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas

Navika D. Shukla, Joseph G. Schroers-Martin, Brian J. Sworder, Karan Raj Kathuria, Stefan K. Alig, Matthew J. Frank, David B. Miklos, Steven Coutre, Maximilian Diehn, Michael S. Khodadoust, Mark Roschewski, David M. Kurtz, Ash A. Alizadeh
Journal: Blood Advances
Blood Adv (2024) 8 (3): 780–784.
https://doi.org/10.1182/bloodadvances.2023011997
Published: 2024
Journal Articles

Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma

Erin A. Dean, Gregory J. Kimmel, Matthew J. Frank, Ali Bukhari, Nasheed M. Hossain, Michael D. Jain, Saurabh Dahiya, David B. Miklos, Philipp M. Altrock, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4608–4618.
https://doi.org/10.1182/bloodadvances.2022009426
Published: 2023
Journal Articles

Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma

Clinical Trials & Observations
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, Patrick M. Reagan, David B. Miklos, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi, Yi Lin, Michael Crump, John Kuruvilla, Eric Van Den Neste, Umar Farooq, Lynn Navale, Venita DePuy, Jenny J. Kim, Christian Gisselbrecht
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4149–4155.
https://doi.org/10.1182/bloodadvances.2020003848
Published: 2021
Includes: Supplemental data
Journal Articles

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Vandana Sundaram, Connie Chen, Ilana Yurkiewicz, Eric Kuo, Sarah Burnash, Jay Y. Spiegel, Sally Arai, Matthew J. Frank, Laura J. Johnston, Robert Lowsky, Everett H. Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Parveen Shiraz, Judith A. Shizuru, Wen-Kai Weng, Michaela Liedtke, Hyma T. Vempaty, David B. Miklos
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3147–3151.
https://doi.org/10.1182/bloodadvances.2021004234
Published: 2021
Includes: Supplemental data
Journal Articles

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

Clinical Trials & Observations
John H. Baird, David J. Epstein, John S. Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig, Gursharan K. Claire, Matthew J. Frank, Lori Muffly, Parveen Shiraz, Everett Meyer, Sally Arai, Janice (Wes) Brown, Laura Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Wen-Kai Weng, Theresa Latchford, Bita Sahaf, Crystal L. Mackall, David B. Miklos, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2021) 5 (1): 143–155.
https://doi.org/10.1182/bloodadvances.2020002732
Published: 2021
Includes: Supplemental data
Journal Articles

Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Frederick L. Locke, John M. Rossi, Sattva S. Neelapu, Caron A. Jacobson, David B. Miklos, Armin Ghobadi, Olalekan O. Oluwole, Patrick M. Reagan, Lazaros J. Lekakis, Yi Lin, Marika Sherman, Marc Better, William Y. Go, Jeffrey S. Wiezorek, Allen Xue, Adrian Bot
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4898–4911.
https://doi.org/10.1182/bloodadvances.2020002394
Published: 2020
Includes: Supplemental data
Journal Articles

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

Clinical Trials & Observations
Michael A. Spinner, Vanessa E. Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Wen-Kai Weng, Richard T. Hoppe, Samuel Strober, Robert Lowsky
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2454–2464.
https://doi.org/10.1182/bloodadvances.2019000297
Published: 2019
Includes: Supplemental data
Journal Articles

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Clinical Trials & Observations
Michael A. Spinner, Marcelo Fernández-Viña, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Judith A. Shizuru, Wen-Kai Weng, Ginna G. Laport, Samuel Strober, Robert Lowsky, Andrew R. Rezvani
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1347–1357.
https://doi.org/10.1182/bloodadvances.2017007716
Published: 2017
Includes: Supplemental data